SANTA CLARA, Calif.–Affymetrix, Inc. (NASDAQ:AFFX) today announced that it has signed a global distribution agreement with Almac Group Ltd., an established company that provides an extensive range of pharmaceutical services. In this agreement, Affymetrix has exclusive rights to distribute Almac’s Xcel™ array for research use in biomarker discovery for multiple disease areas, including cancer. The […]
Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that it has increased its offer price for all outstanding publicly-held shares of Illumina, Inc. (NASDAQ: ILMN) to US$ 51.00 per share in cash. All other terms and conditions of the tender offer remain unchanged. Severin Schwan, Chief Executive Officer of Roche, said: “Based on our discussions […]
Almac today announced that it has signed an exclusive global distribution deal with Affymetrix, Inc. enabling them to directly sell Almac’s proprietary Xcel™ array for biomarker discovery, development and delivery worldwide. Almac’s Xcel™ array is a high density transcriptome-based microarray that has been optimised for the discovery and development of biomarkers from formalin fixed paraffin […]
Qlucore, a world leader in the development of bioinformatics software, has today announced an agreement with Filgen, Inc, one of Japan’s leading specialists in sales of science research equipment. Since its launch in 2004, Filgen has earned an international reputation for its work within the biotechnology and pharmaceutical sectors, including its highly regarded Biotechnology Analysis […]
SANTA CLARA, Calif.,- Agilent Technologies Inc. today released GeneSpring 12.0, a major expansion of its popular bioinformatics software designed to enable a new level of medical science breakthroughs. With the new release, GeneSpring users can now analyze next-generation sequencing data and conduct joint analysis at the pathway level across multiple “omics” platforms in a familiar […]
The agreement enables close collaboration between a research centre whose principal mission is the study of the genome and how it translates into characteristics that distinguish each individual, and an industry leader whose technology and products accelerate genetic analysis research and applications, paving the way for molecular medicine and ultimately transforming healthcare. “This is the […]
Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that it has extended its cash tender offer to acquire all outstanding shares of Illumina, Inc. (NASDAQ: ILMN), at a price of $44.50 per share, to 6:00 p.m., New York City time, on April 20, 2012. The tender offer was previously scheduled to expire at 6:00 p.m., […]
SAN DIEGO — Illumina, Inc. (NASDAQ: ILMN), a leading developer, manufacturer, and marketer of life science tools and integrated systems for the analysis of genetic variation and function, today issued the following statement regarding Roche’s decision to extend for the second time its unsolicited tender offer to acquire all outstanding shares of Illumina for $44.50 […]
SAN DIEGO– Illumina, Inc. (NASDAQ:ILMN), a leading developer, manufacturer, and marketer of life science tools and integrated systems for the analysis of genetic variation and function, today sent a second letter to its stockholders outlining Illumina’s unrivaled track record of superior operational performance and financial success. The letter urges stockholders to reject Roche’s efforts to […]
ST. LOUIS, MO — MOgene, LC, a leading NimbleGen Service provider based in St. Louis, MO, has announced the signing of an agreement with Lawrence Livermore National Laboratory (LLNL) to provide services using the Lawrence Livermore Microbial Detection Array (LLMDA). The technology of the LLMDA, which includes probes for more than 3,000 bacterial and viral […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
